These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38652192)

  • 1. Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress.
    Costa RGA; Oliveira MS; Rodrigues ACBDC; Silva SLR; Dias IRSB; Soares MBP; de Faro Valverde L; Gurgel Rocha CA; Dias RB; Bezerra DP
    J Cell Mol Med; 2024 Apr; 28(8):e18333. PubMed ID: 38652192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emetine induces oxidative stress, cell differentiation and NF-κB inhibition, suppressing AML stem/progenitor cells.
    Silva SLR; Dias IRSB; Rodrigues ACBDC; Costa RGA; Oliveira MS; Barbosa GADC; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Roy N; Park CY; Bezerra DP
    Cell Death Discov; 2024 Apr; 10(1):201. PubMed ID: 38684672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bithionol eliminates acute myeloid leukaemia stem-like cells by suppressing NF-κB signalling and inducing oxidative stress, leading to apoptosis and ferroptosis.
    Dias IRSB; Costa RGA; Rodrigues ACBDC; Silva SLR; Oliveira MS; Soares MBP; Dias RB; Valverde LF; Gurgel Rocha CA; Cairns LV; Mills KI; Bezerra DP
    Cell Death Discov; 2024 Aug; 10(1):390. PubMed ID: 39209810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
    Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
    Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.
    Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y
    Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
    Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
    Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma.
    Yao Y; Zhang Y; Shi M; Sun Y; Chen C; Niu M; Zhang Q; Zeng L; Yao R; Li H; Yang J; Li Z; Xu K
    J Leukoc Biol; 2018 Dec; 104(6):1105-1115. PubMed ID: 30024656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33-dependent NF-κB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia.
    Yan M; Chen X; Ye Q; Li H; Zhang L; Wang Y
    Cytokine; 2024 Aug; 180():156672. PubMed ID: 38852492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
    Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
    Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WTAP and m
    Iaiza A; Mazzanti G; Goeman F; Cesaro B; Cortile C; Corleone G; Tito C; Liccardo F; De Angelis L; Petrozza V; Masciarelli S; Blandino G; Fanciulli M; Fatica A; Fontemaggi G; Fazi F
    Cell Mol Life Sci; 2024 Jun; 81(1):276. PubMed ID: 38909325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase.
    Wang X; Gao M; Zhang J; Ma Y; Qu W; Liang J; Wu H; Wen H
    Redox Biol; 2019 Jun; 24():101153. PubMed ID: 30909158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
    Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying synergism between circularized tumor necrosis factor-related apoptosis inducing ligand and bortezomib in bortezomib-sensitive or -resistant myeloma cells.
    Leng Y; Hu X; Li L; Nkwocha J; Satta T; Sharma K; Kmeiciak M; Zhou H; Zhang Z; Zhou L; Chen W; Grant S
    Hematol Oncol; 2022 Dec; 40(5):999-1008. PubMed ID: 35789025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.
    Su Z; Han S; Jin Q; Zhou N; Lu J; Shangguan F; Yu S; Liu Y; Wang L; Lu J; Li Q; Cai L; Wang C; Tian X; Chen L; Zheng W; Lu B
    Cell Death Dis; 2021 Mar; 12(3):251. PubMed ID: 33674562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piplartine eliminates CD34 + AML stem/progenitor cells by inducing oxidative stress and suppressing NF-κB signalling.
    Rodrigues ACBDC; Silva SLR; Dias IRSB; Costa RGA; Oliveira MS; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Johnson EM; Pina C; Bezerra DP
    Cell Death Discov; 2024 Mar; 10(1):147. PubMed ID: 38503729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.